中年动脉粥样硬化与阿尔茨海默病或血管性痴呆的发生
基于瑞典马尔默饮食与癌症研究心血管队列(N=6,103),基线(1991-1994)测量颈动脉斑块和内中膜厚度,随访至2014年评估痴呆发病。结果显示中年内中膜厚度较高与全因痴呆和血管性痴呆风险增加相关,但与阿尔茨海默病痴呆无关;在认知正常亚组中,内中膜厚度与脑小血管病相关,而与脑脊液AD生物标志物无显著关联。
要点
- 中年颈动脉内中膜厚度较高与血管性痴呆风险增加相关。
- 颈动脉斑块评分与血管性痴呆风险增加相关。
- 动脉粥样硬化与阿尔茨海默病痴呆或AD病理无显著关联。
核心结论
- 中年动脉粥样硬化与血管性痴呆和脑小血管病发生相关,但与阿尔茨海默病痴呆或AD病理无关。
研究设计与样本
- 瑞典前瞻性人群队列马尔默饮食与癌症研究心血管队列,N=6,103,基线1991-1994年测量颈动脉斑块和内中膜厚度,随访至2014年。
- 认知正常亚组n=330,2009-2015年检测脑脊液β-淀粉样蛋白42和tau,并用MRI评估白质高信号体积、腔隙性梗死和脑微出血。
主要发现
- 20年随访期间462人发生痴呆,基线平均年龄57.5±5.9岁,58%为女性。
- 中年内中膜厚度较高与全因痴呆风险增加相关(调整HR=1.14,95%CI 1.03-1.26)。
- 中年内中膜厚度较高与血管性痴呆风险增加相关(调整HR=1.32,95%CI 1.10-1.57),但与阿尔茨海默病痴呆无关(调整HR=0.95,95%CI 0.77-1.17)。
- 颈动脉斑块以3级评分评估时与血管性痴呆相关(调整HR=1.90,95%CI 1.07-3.38)。
- 认知正常亚组中,中年内中膜厚度较高与脑小血管病发生相关(调整OR=1.47,95%CI 1.05-2.06),与脑脊液AD生物标志物无显著关联(Aβ42调整OR=1.28,95%CI 0.87-1.90;Aβ42/p-tau调整OR=1.35,95%CI 0.86-2.13)。
临床怎么用
- 中年颈动脉内中膜厚度和斑块评估可能有助于识别血管性痴呆高风险个体。
- 对于中年动脉粥样硬化患者,应关注脑小血管病的预防和管理。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether midlife atherosclerosis is associated with different dementia subtypes and related underlying pathologies. METHODS: Participants comprised the cardiovascular cohort of the Swedish prospective population-based Malmö Diet and Cancer Study (N = 6,103). Carotid plaques and intima media thickness (IMT) were measured at baseline (1991-1994). Dementia incidence until 2014 was obtained from national registers. Diagnoses were reviewed and validated in medical records. In a cognitively unimpaired subcohort (n = 330), β-amyloid42 and tau were quantified in cerebrospinal fluid (CSF), and white matter hyperintensity volume, lacunar infarcts, and cerebral microbleeds were estimated on magnetic resonance imaging (2009-2015). RESULTS: During 20 years of follow-up, 462 individuals developed dementia (mean age at baseline = 57.5 ± 5.9 years, 58% women). Higher IMT in midlife was associated with an increased hazard ratio (HR) of all-cause dementia (adjusted HR = 1.14 [95% confidence interval (CI) = 1.03-1.26]) and vascular dementia (adjusted HR = 1.32 [95% CI = 1.10-1.57]) but not Alzheimer disease (AD) dementia (adjusted HR = 0.95 [95% CI = 0.77-1.17]). Carotid plaques were associated with vascular dementia when assessed as a 3-graded score (adjusted HR = 1.90 [95% CI = 1.07-3.38]). In the cognitively unimpaired subcohort (53.8 ± 4.6 years at baseline, 60% women), higher IMT in midlife was associated with development of small vessel disease (adjusted odds ratio [OR] = 1.47 [95% CI = 1.05-2.06]) but not significantly with abnormal CSF AD biomarkers (adjusted OR = 1.28 [95% CI = 0.87-1.90] for Aβ42 and 1.35 [95% CI = 0.86-2.13] for Aβ42 /p-tau). Carotid plaques revealed no significant association with any of the underlying brain pathologies. INTERPRETATION: Our findings support an association between midlife atherosclerosis and development of vascular dementia and cerebral small vessel disease but not between atherosclerosis and subsequent AD dementia or AD pathology. ANN NEUROL 2020;87:52-62.
引用
- Gustavsson AM, van Westen D, Stomrud E, et al. Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia. Ann Neurol. 2019. PMID: 31721283. doi:10.1002/ana.25645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。